Clinical trials
Withdrawn Alzheimer Disease trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 2 |
| Massachusetts General Hospital | 2 |
| Northwestern University | 2 |
| Tammie L. S. Benzinger, MD, PhD | 2 |
| Wake Forest University Health Sciences | 2 |
| Weill Medical College of Cornell University | 2 |
| Ageless Regenerative Institute | 1 |
| Ali Rezai | 1 |
| Allergan | 1 |
| AnthroTronix, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 41 |
| Dementia | 12 |
| Cognitive Dysfunction | 9 |
| Anxiety Disorders | 3 |
| Amyloidosis | 2 |
| Brain Diseases | 2 |
| Memory Disorders | 2 |
| Neurodegenerative Diseases | 2 |
| Amyloid Neuropathies, Familial | 1 |
| Amyloidosis, Familial | 1 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.